Skip to main content
. 2021 Apr 24;13(5):1442. doi: 10.3390/nu13051442

Table 3.

Comorbidities associated with NAFLD and NASH, respectively, based on a meta-analysis [13].

Comorbidities NAFLD NASH
Obesity 51% 82%
Hypertension 39% 67%
Type 2 diabetes mellitus 23% 47%
Hyperlipidaemia/dyslipidaemia 69% 72%
Metabolic syndrome 41% 71%

Abbreviations: NAFLD: non-alcoholic fatty liver disease; NASH: non-alcoholic steatohepatitis.